July 30th, 2022A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.

June 23rd, 2022Today is Stanley Tono Cornejo's 50th Birthday. Please send good wishes and prayers to his family.

June 17th, 2022Inhibrx submitted the attached poster at the American Society of Clinical Oncology ASCO Conference last month. It addresses the Phase 2 study and the locations where they plan to have their our pivotal study for the medication INBRX-109. The best...

June 14th, 2022The Bone Cancer Research Trust has a 12 page comprehensive fact sheet on Chondrosarcoma. It defines Chondrosarcoma, who it affects, the symptoms, sub-types, causes and risk factors, diagnosing, treatment, follow-up, rehabilitation and support. For...

June 9th, 2022Mesenchymal Chondrosarcoma of the Head and Neck with HEY1::NCOA2 Fusion: a Clinicopathologic and Molecular Study of 13 Cases with Emphasis on Diagnostic Pitfalls Bin Xu 1, Lisa M Rooper 2, Josephine K Dermawan 1, Yanming Zhang 1, Albert J H...

May 16th, 2022The Chondrosarcoma Foundation, Inc. hosted their fourth International Virtual Dialogue on April 30, 2022; featuring the prominent experts to address new innovations, findings and technologies to improve the treatment of Chondrosarcoma. The videos...

May 10th, 2022BOWIE, Maryland, May 10—The Chondrosarcoma (CS) Foundation will commemorate its second anniversary by continuing to educate the public about this rare bone cancer and advocate for patients fighting the disease. On May 14, 2020, the CS Foundation...

April 28th, 2022LAST CALL TO REGISTER Virtual Dialogue is Three Days From Today In the spirit of sharing and passing knowledge about Chondrosarcoma, we invite you to attend our fourth virtual dialogue. The event is free, there are no fees and all we need is...